FDA wants to relax approval process for Alzheimer's drugs
(HealthDay)—In an effort to quickly develop drugs that could prevent or slow Alzheimer's, the U.S. Food and Drug Administration said it plans to relax the approval process for experimental medications for the memory-robbing ...
Mar 14, 2013
0
0